For the 16 million people globally and 3 million people in the U.S. suffering from opioid use disorder (OUD), COVID-19 brings a slew of issues: lack of face-to-face counseling services, methadone clinic shutdown and increased mortality risk from coronavirus from underlying respiratory damage.